History | Enzalutamide for hormone-relapsed non-metastatic prostate cancer | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 153 KB)

Published:

15 May 2019

Final draft guidance

Final draft guidance
Final appraisal document (PDF 275 KB)

Published:

05 April 2019
Committee papers (PDF 738 KB)

Published:

05 April 2019
Public committee slides (PDF 530 KB)

Published:

05 April 2019

Draft guidance

Draft guidance
Appraisal consultation document (PDF 289 KB)

Published:

24 January 2019
Committee papers (PDF 4.14 MB)

Published:

24 January 2019

Invitation to participate

Final scope (PDF 85 KB)

Published:

13 July 2018
Final matrix (PDF 90 KB)

Published:

13 July 2018
NICE's response to comments on the draft scope and provisional matrix (PDF 139 KB)

Published:

13 July 2018
Equality impact assessment (Scoping) (PDF 72 KB)

Published:

13 July 2018

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft scope post referral (PDF 310 KB)

Published:

21 February 2018
Draft matrix post referral (PDF 264 KB)

Published:

21 February 2018